Little did I realize a few grapes could send my blood sugar soaring until I tried the first glucose monitor without a ...
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, in ...
San Diego’s Dexcom began sales this week of Stelo, the industry’s first FDA-approved continuous glucose monitor that doesn’t require a prescription. With a two-pack of the biosensor costing ...
Dexcom‘s Stelo glucose monitor is for those people and I’ve found it works pretty well. It’s available today as the first blood sugar monitor for people who don’t have diabetes yet ...
The company, which manufactures CGM devices, partnered with Allison PR for a campaign that aimed to spread awareness of life ...
As a leading CGM maker, DexCom is likely to play a significant role in diabetes care for years, possibly decades. Given all ...
I managed to lose seven pounds. SAN DIEGO, September 18, 2024--DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced ...
DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...
NEW YORK, Sept. 23, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of DexCom, Inc. (NASDAQ: DXCM).
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback